ATRX Antibodies

Minasi, Baldi, Pietsch, Donofrio, Pollo, Antonelli, Massimino, Giangaspero, Buttarelli: "Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood." in: Journal of neuro-oncology, Vol. 142, Issue 3, pp. 435-444, (2019) (PubMed).

Li, Oh, Song, Shin, Zhang, Freeman, Janknecht: "A potential common role of the Jumonji C domain-containing 1A histone demethylase and chromatin remodeler ATRX in promoting colon cancer." in: Oncology letters, Vol. 16, Issue 5, pp. 6652-6662, (2018) (PubMed).

Wille, Amort, Singewald, Sartori, Lusser: "Dysregulation of select ATP-dependent chromatin remodeling factors in high trait anxiety." in: Behavioural brain research, Vol. 311, pp. 141-6, (2016) (PubMed).

Fishbein, Khare, Wubbenhorst, DeSloover, DAndrea, Merrill, Cho, Greenberg, Else, Montone, LiVolsi, Fraker, Daber, Cohen, Nathanson: "Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas." in: Nature communications, Vol. 6, pp. 6140, (2015) (PubMed).

Hayashi, Sasaki, Kimura, Abe, Nakamura, Kitamura, Miwa, Kameyama, Hirose, Yoshida: "Molecular-genetic and clinical characteristics of gliomas with astrocytic appearance and total 1p19q loss in a single institutional consecutive cohort." in: Oncotarget, Vol. 6, Issue 18, pp. 15871-81, (2015) (PubMed).

Napier, Huschtscha, Harvey, Bower, Noble, Hendrickson, Reddel: "ATRX represses alternative lengthening of telomeres." in: Oncotarget, Vol. 6, Issue 18, pp. 16543-58, (2015) (PubMed).

Yoshida, Ogawa, Yoshida, Maeshima, Kanai, Kinoshita, Hiraoka, Sekine: "TERT promoter mutations are frequent and show association with MED12 mutations in phyllodes tumors of the breast." in: British journal of cancer, Vol. 113, Issue 8, pp. 1244-8, (2015) (PubMed).

Wille, Maurer, Piatti, Whittle, Rieder, Singewald, Lusser: "Impaired Contextual Fear Extinction Learning is Associated with Aberrant Regulation of CHD-Type Chromatin Remodeling Factors." in: Frontiers in behavioral neuroscience, Vol. 9, pp. 313, (2015) (PubMed).

Cairncross, Wang, Jenkins, Shaw, Giannini, Brachman, Buckner, Fink, Souhami, Laperriere, Huse, Mehta, Curran: "Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH." in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 32, Issue 8, pp. 783-90, (2014) (PubMed).

Haberler, Wöhrer: "Clinical Neuropathology practice news 2-2014: ATRX, a new candidate biomarker in gliomas." in: Clinical neuropathology, Vol. 33, Issue 2, pp. 108-11, (2014) (PubMed).